Cargando…
Examining reporting and representation of patients with cancer in COVID‐19 clinical trials
BACKGROUND: Patients with cancer are particularly vulnerable in the current COVID‐19 pandemic. Emerging evidence suggests that patients with a cancer diagnosis are three times more likely to die from COVID‐19 compared to non‐cancer patients. Due to these observed risks, it is critical that emerging...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7995191/ https://www.ncbi.nlm.nih.gov/pubmed/33621447 http://dx.doi.org/10.1002/cnr2.1355 |